A phase I study of pazopanib in combination with escalating doses of 131I in patients with well-differentiated thyroid carcinoma borderline refractory to radioiodine

Open Access

Peer-reviewed

Research Article

A phase I study of pazopanib in combination with escalating doses of ¹³¹I in patients with well-differentiated thyroid carcinoma borderline refractory to radioiodine

Laura Q. Chow ,

* E-mail: lqchow@u.washington.edu

Affiliation Department of Medicine, Division of Medical Oncology, University of Washington, Fred Hutchison Cancer Research Center, Seattle, WA, United States of America
⨯
Rafael Santana-Davila,

Affiliation Department of Medicine, Division of Medical Oncology, University of Washington, Fred Hutchison Cancer Research Center, Seattle, WA, United States of America

http://orcid.org/0000-0001-5051-1755

⨯
Austin Pantel,

Affiliation Department of Nuclear Medicine, University of Pennsylvania, Philadelphia, PA, United States of America
⨯
Mara Roth,

Affiliation Department of Medicine, Division of Endocrinology, University of Washington, Seattle, WA, United States of America
⨯
Leslie N. Anderson,

Affiliation Department of Medicine, Division of Medical Oncology, University of Washington, Fred Hutchison Cancer Research Center, Seattle, WA, United States of America
⨯
Alan Failor,

Affiliation Department of Medicine, Division of Endocrinology, University of Washington, Seattle, WA, United States of America
⨯
Robert Doot,

Affiliation Department of Nuclear Medicine, University of Pennsylvania, Philadelphia, PA, United States of America
⨯
David Mankoff

Affiliation Department of Nuclear Medicine, University of Pennsylvania, Philadelphia, PA, United States of America
⨯

Iodine
Is the Subject Area "Iodine" applicable to this article?

Thanks for your feedback.
Toxicity
Is the Subject Area "Toxicity" applicable to this article?

Thanks for your feedback.
Thyroid carcinoma
Is the Subject Area "Thyroid carcinoma" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Metastasis
Is the Subject Area "Metastasis" applicable to this article?

Thanks for your feedback.
Radiation therapy
Is the Subject Area "Radiation therapy" applicable to this article?

Thanks for your feedback.
Lesions
Is the Subject Area "Lesions" applicable to this article?

Thanks for your feedback.
Thyroglobulin
Is the Subject Area "Thyroglobulin" applicable to this article?

Thanks for your feedback.